Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Fuji
US Department of Justice
Moodys
Harvard Business School
QuintilesIMS
Federal Trade Commission
Citi

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203752

« Back to Dashboard

NDA 203752 describes MINIVELLE, which is a drug marketed by Noven and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and two Paragraph IV challenges. Additional details are available on the MINIVELLE profile page.

The generic ingredient in MINIVELLE is estradiol. There are seventy-five drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 203752
Tradename:MINIVELLE
Applicant:Noven
Ingredient:estradiol
Patents:5
Formulation / Manufacturing:see details
Pharmacology for NDA: 203752
Ingredient-typeEstradiol Congeners
Mechanism of ActionEstrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 203752
Suppliers and Packaging for NDA: 203752
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3410 68968-3410-8 8 POUCH in 1 CARTON (68968-3410-8) > 1 d in 1 POUCH (68968-3410-1)
MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3425 68968-3425-8 8 POUCH in 1 CARTON (68968-3425-8) > 1 d in 1 POUCH (68968-3425-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.0375MG/24HR
Approval Date:Oct 29, 2012TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Apr 27, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jul 4, 2030Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jul 10, 2028Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD FOR ADMINISTERING ESTRADIOL COMPRISING A MONOLITHIC TRANSDERMAL DRUG DELIVERY SYSTEM CONSISTING OF (I) A BACKING LAYER AND (II) A SINGLE ADHESIVE POLYMER MATRIX LAYER AS CLAIMED IN US PATENT NO. 9730900

Expired US Patents for NDA 203752

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-001 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-004 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-003 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-002 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-003 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-002 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752-004 Oct 29, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Chubb
Julphar
Harvard Business School
Chinese Patent Office
Fish and Richardson
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.